Showing results (451-460 of 602) with videos related to

Sort By:
Pageof 61
Frontiers in Neurology|May 3, 2021
Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington's DiseaseNina M Mansoor, Tishok Vanniyasingam, Ian Malone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
The ParkinsonNet trial: design and baseline characteristicsSamyra H J Keus, Maarten J Nijkrake, George F Borm, et al.
In Vivo (Athens, Greece)|November 1, 1993
Distribution and kinetics of 131I-labeled human IgM monoclonal antibody 16.88 in patients with advanced colorectal cancerJ C Roos, M A Plaizier, A van Lingen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neckD R Colnot, J J Quak, J C Roos, et al.
Journal of Neuropsychology|October 25, 2013
Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's diseaseEllen P Hart, Eve M Dumas, Erik W van Zwet, et al.
Neurobiology of Disease|June 1, 2011
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease miceJorien M M van der Burg, Annika Winqvist, N Ahmad Aziz, et al.
Journal of Huntington'S Disease|January 11, 2015
Longitudinal metabolite changes in Huntington's disease during disease onsetSimon J A van den Bogaard, Eve M Dumas, Wouter M Teeuwisse, et al.
AJNR. American Journal of Neuroradiology|January 14, 2012
Magnetization transfer imaging in premanifest and manifest Huntington diseaseS J A van den Bogaard, E M Dumas, J Milles, et al.
Pageof 61